Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...

HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant ...

Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, research has demonstrated that combining ADT with additional agents ...

Prostate cancer is one of the most common cancers affecting men around the world. In many countries, including Germany, it is the most frequently diagnosed cancer in men. Each year, about 65,000 men ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

For men who have a detectable PSA of 0.5 ng/mL or less after radical prostatectomy and before salvage radiation therapy, hormone therapy may provide no overall survival or metastasis-free survival ...

Cardio-kidney-metabolic syndrome and prostate cancer: Prognostic significance of higher stages for cardiovascular morbidity and mortality. This is an ASCO Meeting Abstract from the 2026 ASCO ...

Predictors of early termination in phase 2–3 genitourinary oncology trials: A two-decade analysis of clinicaltrials.gov. Patterns of management and multidisciplinary care in high/very high and ...

A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage trial investigated a form of radiotherapy on patients who had stopped ...

aDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA bDepartment of Medicine Statistical Core, University of California, Los Angeles, Los Angeles, CA, USA ...